RESUMO
BACKGROUND: Currently, the first line treatment for Warthin's tumor (WT) is parotidectomy. There is a paucity of data evaluating the safety and efficacy of non-surgical treatments for patients not amenable to surgery. Ultrasound guided ethanol sclerotherapy (UGES) has been successfully used for the management of lymphangiomans of the head and neck, thyroid nodules, and thyroid cysts. This is the first study to implement and assess the success of UGES for management of WT. METHODS: We report two patients with WT, with a total of 3 masses, who underwent UGES. All procedures were performed in the clinic. The primary outcome measured was the tumor volume reduction rate (VRR), patient satisfaction, and complications observed at follow-up. RESULTS: Both patients experienced a significant reduction in tumor size upon follow up. VRR for the three treated tumors were 67.30%, 98.32%, and 55.73%. Patient were very satisfied with the results and noted significant cosmetic improvement. No complications were observed at follow-up. CONCLUSIONS: Ultrasound guided ethanol sclerotherapy may be a viable option for conservative treatment of Warthin's tumor in patients unsuitable or unwilling to undergo surgical resection.
Assuntos
Adenolinfoma/terapia , Tratamento Conservador/métodos , Etanol/administração & dosagem , Neoplasias Parotídeas/terapia , Escleroterapia/métodos , Ultrassonografia de Intervenção/métodos , Adenolinfoma/patologia , Feminino , Seguimentos , Humanos , Injeções Intralesionais , Masculino , Pessoa de Meia-Idade , Neoplasias Parotídeas/patologia , Satisfação do Paciente , Resultado do TratamentoRESUMO
RATIONALE: Parotid gland adenolymphoma is one of the most common benign tumors in parotid gland, and mainly treated by surgery. Despite the widespread of ultrasound-guided percutaneous microwave ablation, there is no report concerning its application in parotid gland adenolymphoma. Herein, we reported a 2-year follow-up result of a male patient underwent ultrasound-guided percutaneous microwave ablation for parotid gland adenolymphoma. PATIENT CONCERNS: A 73-year-old man was admitted due to a hypoechoic nodule measuring 2.67â×â1.42â×â1.35âcm in posterior-inferior area of parotid gland with a high flow velocity in color Doppler flow imaging. DIAGNOSE: The lesion was pathologically diagnosed as parotid gland adenolymphoma. INTERVENTIONS: Ultrasound-guided percutaneous microwave ablation was performed to the tumor due to the fact that the patient refused to receive an open surgery in consideration of older age. OUTCOMES: The ablation procedure lasted about 2âminutes and 15âseconds, without significant adverse effect. The reduction ratios of tumor at postoperative 1 and 3-month were 53% and 82%, respectively. The tumor was fully absent at postoperative 8-month evaluation. Finally, there was no evident recurrence at postoperative 24-month evaluation. LESSONS: Ultrasound-guided percutaneous microwave ablation is a safe and effective treatment for parotid gland adenolymphoma, which may serve as a novel alternative approach for patients unsuitable for open surgery.
Assuntos
Adenolinfoma/terapia , Micro-Ondas/uso terapêutico , Neoplasias Parotídeas/terapia , Ultrassonografia de Intervenção/métodos , Adenolinfoma/diagnóstico por imagem , Idoso , Humanos , Masculino , Neoplasias Parotídeas/diagnóstico por imagem , Ablação por Radiofrequência , Terapia por Radiofrequência , Resultado do Tratamento , Carga Tumoral , Ultrassonografia Doppler em Cores/métodosRESUMO
PURPOSE: Warthin tumour (WT) is the second most common benign tumour of the parotid gland. The aim of this study was to assess the value of the FNAB in the diagnosis and treatment decision in patients with WT. MATERIALS AND METHODS: We performed a retrospective study of patients treated for parotid gland mass between 2006 and 2016. Patients who underwent the surgery with preoperative FNAB were considered. The first group was comprised of patients with preoperative FNAB showing WT and the second group was formed by patients with definitive histology of WT. RESULTS: 216 patients had FNAB with the result of WT and underwent surgery (98 women-45.4% and 118 men-54.6%). The definitive histology corresponded with the preoperative diagnosis in 201 cases (93.1%). The other way round, 222 patients were operated with definitive histology showing WT and we correlated this finding with preoperative FNAB. The result of FNAB corresponded with definitive histology of WT in 201 cases (90.5%). Counted sensitivity and specificity of the ultrasound-guided FNAB for the diagnosis of WT were, respectively: 96.63% (CI 93.19-98.64%) and 96.21 (CI 93.83-97.86%). The accuracy of this method was 96.36% (CI 94.54-97.70%). CONCLUSION: Ultrasound-guided FNAB is a safe, accurate and important method in WT diagnosis. The therapeutic approach can be chosen based on FNAB results correlated with other clinical findings. We propose that when WT is suspected, follow-up or enucleation of the tumour are appropriate treatments. Patient preferences should be also considered.
Assuntos
Adenolinfoma , Biópsia por Agulha Fina/métodos , Glândula Parótida , Neoplasias Parotídeas , Ultrassonografia de Intervenção/métodos , Adenolinfoma/patologia , Adenolinfoma/terapia , Feminino , Humanos , Biópsia Guiada por Imagem/métodos , Masculino , Pessoa de Meia-Idade , Glândula Parótida/diagnóstico por imagem , Glândula Parótida/patologia , Neoplasias Parotídeas/patologia , Neoplasias Parotídeas/terapia , Seleção de Pacientes , Estudos Retrospectivos , Sensibilidade e EspecificidadeAssuntos
Humanos , Masculino , Idoso , Neoplasias Parotídeas/patologia , Adenolinfoma/patologia , Adenoma Pleomorfo/patologia , Neoplasias Primárias Múltiplas/patologia , Glândula Parótida , Neoplasias Parotídeas/terapia , Carcinoma/complicações , Carcinoma/patologia , Carcinoma/terapia , Tomografia Computadorizada por Raios X , Adenolinfoma/terapia , Adenolinfoma/diagnóstico por imagem , Adenoma Pleomorfo/terapia , Biópsia por Agulha Fina , Neoplasias Primárias Múltiplas/complicações , Neoplasias Primárias Múltiplas/terapiaRESUMO
BACKGROUND: We evaluated the diagnostic accuracy of fine-needle aspiration cytology (FNAC) in a large series of benign and malignant parotid tumors. METHODS: The FNAC diagnosis of 821 benign and 175 malignant parotid tumors managed at our department between 1999 and 2017 was correlated with the final histology. RESULTS: FNAC made a correct histopathological diagnosis in 72% of the benign parotid tumors; however, FNAC provided a correct grade in only 34% of the malignant tumors. FNAC correctly identified the histology of 94% of pleomorphic adenomas subsequently confirmed by histopathological examination. The sensitivity, specificity, and diagnostic accuracy of FNAC for detecting malignancy were 82.3%, 98.7%, and 95.9%, respectively. CONCLUSION: FNAC generally provided the correct histological diagnosis for benign tumors. However, the histological evaluation and grading of malignant tumors were poor. Although FNAC showed good sensitivity, specificity, and accuracy, its sensitivity decreased when nondiagnostic cases were included in the analysis.
Assuntos
Adenolinfoma/patologia , Adenoma/patologia , Biópsia por Agulha Fina , Carcinoma/patologia , Neoplasias Parotídeas/patologia , Adenolinfoma/mortalidade , Adenolinfoma/terapia , Adenoma/mortalidade , Adenoma/terapia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma/mortalidade , Carcinoma/terapia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Parotídeas/mortalidade , Neoplasias Parotídeas/terapia , Estudos Retrospectivos , Sensibilidade e Especificidade , Adulto JovemAssuntos
Adenolinfoma/patologia , Adenoma Pleomorfo/patologia , Neoplasias Primárias Múltiplas/patologia , Neoplasias Parotídeas/patologia , Adenolinfoma/diagnóstico por imagem , Adenolinfoma/terapia , Adenoma Pleomorfo/terapia , Idoso , Biópsia por Agulha Fina , Carcinoma/complicações , Carcinoma/patologia , Carcinoma/terapia , Humanos , Masculino , Neoplasias Primárias Múltiplas/complicações , Neoplasias Primárias Múltiplas/terapia , Glândula Parótida , Neoplasias Parotídeas/terapia , Tomografia Computadorizada por Raios XRESUMO
Wstep: Nowotwory majace swoja etiologie w gruczolach slinowych wystepuja rzadko i stanowia ok. 3-10% wszystkich guzów w obrebie glowy i szyi. Material i metody: W latach 2006-2016 w Klinicznym Oddziale Chirurgii Czaszkowo-Szczekowo-Twarzowej Wojskowego Instytutu Medycznego w Warszawie z powodu nowotworów slinianek przyusznych hospitalizowano i leczono 149 pacjentów. Podstawa do analizy byly historie chorób pacjentów, wyniki badan histopatologicznych oraz protokoly zabiegów operacyjnych. Wyniki: W 126 przypadkach guzy byly lagodne, natomiast w 26 guzy zlosliwe. Analizujac wyniki mozna stwierdzic, ze nowotwory - zarówno lagodne, jak i zlosliwe - czesciej wystepowaly u mezczyzn. Sredni wiek calej grupy badanych wynosil 58,3 lat, dla zmian zlosliwych - 65,5 lat, a dla zmian lagodnych byl nieznacznie nizszy i wynosil 56,9 lat. Wsród pacjentów objetych analiza szczyt zachorowalnosci przypadal na przedzial wiekowy 60-69 lat. Ponadto zwraca uwage, iz przedzial ten byl taki sam dla ogólnej liczby guzów, jak i nowotworów lagodnych, natomiast dla nowotworów zlosliwych byl nieznacznie wyzszy i wynosil 70-79 lat. Z analizy zebranego materialu wynika, ze guzy lagodne wystepowaly znamiennie czesciej, stanowiac 84,56% wszystkich guzów. Najczestszymi rozpoznaniami wsród nowotworów lagodnych byly gruczolak wielopostaciowy (adenoma pleomorphicum) oraz gruczolak limfatyczny (adenolymphoma), które stanowily lacznie 93,66%. Rezultaty badan wskazuja, ze wsród nowotworów zlosliwych dominowaly: gruczolakorak polimorficzny o niskiej zlosliwosci (polymorphous low-grade adenocarcinoma) wystepujacy w 26,07% przypadków, gruczolakorak inaczej nieokreslony (adenocarcinoma NOS) oraz rak zrazikowokomórkowy (acinic cell carcinoma). Kazdy z nich stanowil po 13,04% rozpoznan. Jak wynika z przeprowadzonej analizy najczestsza metoda leczenia bylo leczenie chirurgiczne jako metoda stosowana samodzielnie. Wnioski: Uzyskane z retrospektywnej analizy dane koreluja z pismiennictwem krajowym i swiatowym.
Assuntos
Neoplasias Parotídeas/diagnóstico , Neoplasias Parotídeas/terapia , Adenolinfoma/diagnóstico , Adenolinfoma/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/terapia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Otolaringologia , Procedimentos Cirúrgicos Otorrinolaringológicos/estatística & dados numéricos , Neoplasias Parotídeas/epidemiologia , Polônia , Estudos RetrospectivosRESUMO
We conducted a retrospective study to assess the accuracy of fine-needle aspiration cytology (FNAC) in the diagnosis of Warthin tumor and to evaluate the subsequent risk of conservative nonsurgical management. We reviewed the records of 75 patients (76 tumors) with a parotid mass that had been diagnosed as a Warthin tumor by FNAC. This patient population was made up of 64 men and 11 women, aged 46 to 93 years (mean: 67). Of the 76 tumors, 40 were treated with surgical excision and 36 with conservative measures. Histology of the 40 excised parotid masses revealed that 38 (95%) were indeed Warthin tumors, 1 (2.5%) was a low-grade adenocarcinoma, and 1 was benign-not otherwise specified. None of the 36 tumors underwent malignant transformation either clinically or on repeat FNAC (if performed) during a follow-up of 4 to 120 months (mean: 55.5 ± 32.2). We conclude that conservative management of Warthin tumors confidently diagnosed on FNAC may be an option for patients who are unwilling or unable to undergo surgical excision.
Assuntos
Adenocarcinoma/patologia , Adenolinfoma/patologia , Tratamento Conservador , Glândula Parótida/cirurgia , Neoplasias Parotídeas/patologia , Adenocarcinoma/diagnóstico , Adenolinfoma/diagnóstico , Adenolinfoma/terapia , Idoso , Idoso de 80 Anos ou mais , Biópsia por Agulha Fina , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Parotídeas/diagnóstico , Neoplasias Parotídeas/terapia , Estudos Retrospectivos , Sensibilidade e EspecificidadeAssuntos
Adenolinfoma/patologia , Neoplasias Embrionárias de Células Germinativas/patologia , Segunda Neoplasia Primária/patologia , Neoplasias Parotídeas/patologia , Neoplasias das Glândulas Sebáceas/patologia , Neoplasias Testiculares/tratamento farmacológico , Adenolinfoma/diagnóstico por imagem , Adenolinfoma/terapia , Biópsia por Agulha Fina , Diagnóstico Diferencial , Humanos , Linfonodos , Metástase Linfática , Masculino , Pessoa de Meia-Idade , Neoplasias Embrionárias de Células Germinativas/diagnóstico por imagem , Neoplasias Embrionárias de Células Germinativas/tratamento farmacológico , Glândula Parótida/patologia , Neoplasias Parotídeas/diagnóstico por imagem , Neoplasias Parotídeas/terapia , Neoplasias das Glândulas Sebáceas/diagnóstico por imagem , Neoplasias das Glândulas Sebáceas/terapia , Glândulas Sebáceas/patologia , Seminoma/diagnóstico por imagem , Seminoma/tratamento farmacológico , Seminoma/patologia , Neoplasias Testiculares/diagnóstico por imagem , Neoplasias Testiculares/patologia , Tomografia Computadorizada por Raios X , Resultado do TratamentoRESUMO
Brucellosis is a zoonotic systemic infectious disease, and multiorgan involvement is commonly seen, but involvement of the neck is a rare presentation of brucellosis. Granulomatous infections of the parotid gland are extremely rare. Warthin tumor is a well-known benign neoplasm of the salivary glands. In this report, we describe a Warthin tumor associated with Brucella melitensis in the same parotid gland.
Assuntos
Adenolinfoma/microbiologia , Brucella melitensis , Brucelose/complicações , Glândula Parótida/microbiologia , Neoplasias Parotídeas/microbiologia , Adenolinfoma/diagnóstico por imagem , Adenolinfoma/patologia , Adenolinfoma/terapia , Brucelose/diagnóstico por imagem , Brucelose/terapia , Diagnóstico Diferencial , Humanos , Masculino , Pessoa de Meia-Idade , Glândula Parótida/diagnóstico por imagem , Glândula Parótida/patologia , Neoplasias Parotídeas/diagnóstico por imagem , Neoplasias Parotídeas/patologia , Neoplasias Parotídeas/terapia , Tomografia Computadorizada por Raios XRESUMO
Sebaceous lymphadenoma is a rare benign neoplasm presenting predominantly in the parotid gland or in periparotid lymph nodes. It rarely transforms into a malignant tumor. We present a sebaceous lymphadenoma with an unusual clinical presentation with a malignant component, infiltration of lymph nodes, and lymphangiosis carcinomatosa. Sebaceous lymphadenoma usually presents as a well-circumscribed, painless, infraauricular mass. In our 87-years-old male patient, the clinical presentation was confluent reddish livid plaques at the left cheek and the left neck. In addition, cervical lymph node metastases were suspected. After skin biopsy, the tumor was excised by parotidectomy, skin excision, and neck dissection followed by a postoperative radiotherapy. To our knowledge, this is the sixth reported case of sebaceous lymphadenocarcinoma and the first case presenting with cervical lymph node metastases and dermatological symptoms revealing lymphangiosis carcinomatosa.
Assuntos
Adenocarcinoma/diagnóstico , Adenolinfoma/diagnóstico , Eritema/patologia , Linfangioleiomiomatose/diagnóstico , Neoplasias Parotídeas/diagnóstico , Neoplasias das Glândulas Sebáceas/diagnóstico , Adenocarcinoma/complicações , Adenocarcinoma/terapia , Adenolinfoma/complicações , Adenolinfoma/terapia , Idoso de 80 Anos ou mais , Biomarcadores Tumorais , Bochecha , Humanos , Linfonodos/patologia , Linfangioleiomiomatose/complicações , Metástase Linfática , Masculino , Esvaziamento Cervical , Glândula Parótida/cirurgia , Neoplasias Parotídeas/complicações , Neoplasias Parotídeas/terapia , Radioterapia Adjuvante , Neoplasias das Glândulas Sebáceas/complicações , Neoplasias das Glândulas Sebáceas/terapiaRESUMO
OBJECTIVE: Local excision surgical procedures and non-surgical conservative management are considered alternatives to superficial parotidectomy in the treatment and management of Warthin's tumour (WT). Such therapeutic alternatives demand accurate diagnosis. In order to determine whether fine needle aspiration cytology (FNAC) is capable of rendering such a minimally invasive diagnosis, we evaluated its accuracy and diagnostic parameters in a large series of histologically proven cases of WT. METHODS: A cytohistological study of 116 salivary tumours from 110 patients (four WT were bilateral) with a histological or cytological diagnosis of WT. RESULTS: Histology confirmed the cytological diagnosis in 103 of 114 tumours (90.4%). Two tumours were incorrectly diagnosed on cytology as WT. In 11 cases of WT there was an erroneous or non-representative cytological diagnosis. The sensitivity was 90.4%, and positive predictive value 98.1%. Regarding malignancy, there were three misdiagnoses. One tumour diagnosed as WT was a low-grade mucoepidermoid carcinoma. Two cases considered 'suspicious of squamous cell carcinoma' corresponded to WT. After review, 81.3% of the cases of WT were considered typical and 18.7% non-typical; all misdiagnoses were in the latter group. Cytological difficulties could be divided into three areas: (i) absence of one or more diagnostic components; (ii) 'squamoid' pattern; and (iii) mucinous metaplasia. Degenerated oncocytes were present in 65% of cases. CONCLUSIONS: FNAC offers the possibility of a reliable diagnosis of WT. Pathologists must pay attention to the squamous appearance of degenerated oncocytes. Cytology, when coupled with clinical and image findings, may permit conservative tumour management.
Assuntos
Adenolinfoma/diagnóstico , Adenolinfoma/terapia , Neoplasias das Glândulas Salivares/diagnóstico , Neoplasias das Glândulas Salivares/terapia , Glândulas Salivares/patologia , Adenolinfoma/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia por Agulha Fina , Carcinoma de Células Escamosas/patologia , Reações Falso-Negativas , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias das Glândulas Salivares/patologiaRESUMO
Carcinomas arising in or from the epithelial component of preexisting parotid Warthin tumors (WTs) are rare; the other histologic types of carcinoma found to arise from WTs are adenocarcinoma not otherwise specified, undifferentiated, mucoepidermoid, squamous cell, and oncocytic. The aim of this study is to describe the clinicopathologic features of a distinct salivary gland neoplasm, previously undescribed, with a striated duct phenotype arising from WT. We have designated this neoplasm "Warthin adenocarcinoma" (WA). In this retrospective study, we searched the surgical pathology files of the Department of Pathology at The University of Texas M.D. Anderson Cancer Center for cases of malignant WT and salivary adenocarcinoma not otherwise specified diagnosed from January 1, 1985, through December 31, 2006, and evaluated patients' medical records and pathologic material. We obtained tissue sections and immunohistochemically stained them with antibodies against p63; Bcl-2; cytokeratin (CK)903, CK7, CK14, and CK18; antimitochondrial antibody (AMA); smooth muscle actin; calponin; S-100; and Ki-67. We identified 2 cases of WA; both patients were women, 44 and 60 years of age, with 4.0- and 4.5-cm tumors in the left parotid gland. Histologically, the tumors were composed of bilayered duct-like structures: The inner layer was formed by a single row of columnar oxyphilic cells expressing CK7, CK14, CK18, and AMA. The outer layer was composed of multiple layers of small round dark cells with scanty cytoplasm that expressed p63, Bcl-2, and CK903 and were focally positive for AMA and negative for myoepithelial markers. The Ki-67 proliferative indices were 20%; and 25%. A residual WT with transition to carcinoma was identified in both cases. Treatment had consisted of total parotidectomy with postoperative irradiation. Patients were free of disease 1 and 3 years after treatment. Warthin adenocarcinoma is a unique salivary gland carcinoma representing the malignant epithelial counterpart of WT. The identification of additional cases would help to better elucidate the line of differentiation of the tumor and further define its natural history.
Assuntos
Adenocarcinoma/patologia , Adenolinfoma/patologia , Neoplasias das Glândulas Salivares/patologia , Adenocarcinoma/metabolismo , Adenocarcinoma/terapia , Adenolinfoma/metabolismo , Adenolinfoma/terapia , Adulto , Terapia Combinada , Feminino , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Procedimentos Cirúrgicos Bucais , Radioterapia , Estudos Retrospectivos , Neoplasias das Glândulas Salivares/metabolismo , Neoplasias das Glândulas Salivares/terapiaRESUMO
Warthin tumour is the second most common benign neoplasm of the parotid gland. It has a low rate of growth and exhibits malignant transformation in 0.3% of cases. Although its aggressiveness has not been a concern, surgical resection remains the most common treatment modality. This entails the risk of a general anaesthetic and those pertaining to the procedure itself, most notably permanent facial nerve damage. This has led some authors to use conservative management, albeit rarely. There are those who condemn such a policy despite the encouraging results reported thus far. To understand the rationale underpinning non-operative management, it is imperative that one has a comprehensive understanding of the pathogenesis, clinical presentation and diagnosis of Warthin tumour. The aim of this review therefore is to detail these elements and clarify the current controversies in managing this lesion.
Assuntos
Adenolinfoma/terapia , Neoplasias Parotídeas/terapia , Adenolinfoma/diagnóstico , Biópsia por Agulha Fina , Diagnóstico por Imagem , Humanos , Neoplasias Parotídeas/diagnósticoRESUMO
PURPOSE: The aim of the present study was to analyze the clinical presentation, histopathology, and complications of parotid tumors, as well as the management of malignant parotid tumors. METHODS: We retrospectively reviewed the medical records of 271 patients who underwent parotidectomy from August 1996 to July 2006. Data including age, sex, clinical signs and symptoms, histologic findings, complications, malignant tumor stage, and prognosis were collected from medical charts. RESULTS: Of the 271 patients who underwent parotidectomy, 229 (85%) had benign tumors, 33 (12%) had malignant tumors, and 9 had chronic inflammatory disease (3%). The most common benign tumor was pleomorphic adenoma (51%), and the most common malignant tumor was mucoepidermoid carcinoma (3%). The 5-year overall survival rate was 42%, and the disease-specific survival rate for malignant tumor was 72%. Only disease stage was the statistically significant prognostic factor of malignancy. The most common complication of parotidectomy was transient facial palsy (18%). CONCLUSIONS: Standardized superficial and total parotidectomy are safe procedures for treating parotid tumors. Management of malignant tumors depends on tumor stage and histologic grade. Advanced tumor stage is a predictor of poor outcome.
Assuntos
Neoplasias Parotídeas/patologia , Neoplasias Parotídeas/terapia , Adenolinfoma/mortalidade , Adenolinfoma/patologia , Adenolinfoma/terapia , Adenoma Oxífilo/mortalidade , Adenoma Oxífilo/patologia , Adenoma Oxífilo/terapia , Adenoma Pleomorfo/mortalidade , Adenoma Pleomorfo/patologia , Adenoma Pleomorfo/terapia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma/mortalidade , Carcinoma/patologia , Carcinoma/terapia , Criança , Paralisia Facial/etiologia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Esvaziamento Cervical , Recidiva Local de Neoplasia , Estadiamento de Neoplasias , Neoplasias Parotídeas/mortalidade , Complicações Pós-Operatórias , Prognóstico , Radioterapia Adjuvante , Reoperação , Estudos RetrospectivosRESUMO
BACKGROUND: Warthin tumour (WT) is usually treated by surgery to establish a histologic diagnosis. Conservative management is considered appropriate for patients with significant comorbidities, making anesthesia high risk. Preoperative fine-needle aspiration cytology (FNAC) is useful in diagnosing WT, making conservative management an option. In our institution, patients with an FNAC diagnostic of WT have the option of conservative management. METHOD: Retrospective review of cases of WT over 10 years (1996-2006) to study the demographics of patients treated conservatively and surgically and to establish the accuracy of FNAC. RESULTS: Eighty-six cases of WT were identified during the study period for which FNAC was diagnostic, of which 58 cases (67.4%) were treated conservatively and 28 cases (32.6%) were treated by superficial parotidectomy. A further seven cases of WT were diagnosed on histology as the corresponding FNAC was incorrect in two cases and nondiagnostic in five cases. With regard to WT, FNAC in our unit had a sensitivity of 80% and a specificity of 100%. Females accounted for 54.7% of cases, which is much higher than previously reported and likely reflects the high prevalence of smoking among females in Liverpool. CONCLUSION: Conservative management for WT on the basis of a diagnostic FNAC was employed in 67.4% of cases. This included young patients who preferred to avoid surgery. Conservative management is a viable option if reliable cytologic reporting is available.
Assuntos
Adenolinfoma/patologia , Adenolinfoma/terapia , Biópsia por Agulha Fina/métodos , Neoplasias Parotídeas/patologia , Neoplasias Parotídeas/terapia , Adenolinfoma/mortalidade , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Neoplasias Parotídeas/mortalidade , Estudos Retrospectivos , Medição de Risco , Sensibilidade e Especificidade , Fatores Sexuais , Taxa de Sobrevida , Resultado do TratamentoRESUMO
BACKGROUND: During the pathologic examination of neck dissections, unexpected pathologic findings may occasionally be encountered. These pathologic findings may simulate malignant disease and/or have implications on the already complicated management of patients with head and neck cancer. METHODS: We retrospectively reviewed 202 consecutive patients with a preoperative diagnosis of squamous cell carcinoma (SCC), who underwent 307 neck dissections performed by a single surgeon and examined by a single pathologist. RESULTS: Ten patients had an unexpected finding. These included metastatic papillary thyroid carcinoma, leukemia, lymphoma, Warthin's tumor, and tuberculosis. Two of three patients with benign-appearing thyroid tissue within lymph nodes received no further treatment, and both remained well beyond 6 years. Four patients succumbed to SCC; none died from the incidentally discovered pathologic findings. CONCLUSIONS: Unexpected pathologic findings may be present in more than 3% of neck dissections. Although this is usually indolent, with the underlying SCC remaining the main prognostic determinate, it may significantly complicate postoperative management.
Assuntos
Carcinoma de Células Escamosas/cirurgia , Neoplasias de Cabeça e Pescoço/cirurgia , Esvaziamento Cervical , Adenolinfoma/patologia , Adenolinfoma/terapia , Idoso , Idoso de 80 Anos ou mais , Carcinoma Papilar/patologia , Carcinoma Papilar/secundário , Carcinoma Papilar/cirurgia , Cartilagem Cricoide/patologia , Feminino , Humanos , Leucemia Linfocítica Crônica de Células B/patologia , Leucemia Linfocítica Crônica de Células B/terapia , Metástase Linfática , Linfoma de Células B/patologia , Linfoma de Células B/terapia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Neoplasias da Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/secundário , Neoplasias da Glândula Tireoide/cirurgia , Tireoidectomia , Tuberculose dos Linfonodos/tratamento farmacológico , Tuberculose dos Linfonodos/patologiaRESUMO
Primary sebaceous neoplasms of the salivary glands are extremely rare occurrences; furthermore, sebaceous lymphadenocarcinoma has only been reported in three patients. We report a case of sebaceous lymphadenocarcinoma arising in a lymphadenoma of the parotid gland. The patient was a 55-year-old man who presented with a parotid mass of 3 years' duration. Histologically, the lesion consisted of a sebaceous lymphadenoma with transition to a sebaceous carcinoma. The cytologic touch-preparation at the time of frozen section showed clusters of benign sebaceous cells in a rich lymphocytic background together with tridimensional clusters of malignant epithelial cells, strongly raising the suspicion of a malignant neoplasm arising in a benign sebaceous lesion. Malignant transformation of the sebaceous lymphadenoma, although rare, should be considered in enlarging, locally invasive parotid lesions, considering that clinical behavior and prognosis will be determined by the nature of the malignant component.
Assuntos
Adenocarcinoma/patologia , Adenolinfoma/patologia , Neoplasias Parotídeas/patologia , Neoplasias das Glândulas Sebáceas/patologia , Glândulas Sebáceas/patologia , Adenocarcinoma/metabolismo , Adenocarcinoma/terapia , Adenolinfoma/metabolismo , Adenolinfoma/terapia , Biomarcadores Tumorais/metabolismo , Humanos , Imuno-Histoquímica , Queratinas/metabolismo , Masculino , Pessoa de Meia-Idade , Neoplasias Parotídeas/metabolismo , Neoplasias Parotídeas/terapia , Radioterapia Adjuvante , Neoplasias das Glândulas Sebáceas/metabolismo , Neoplasias das Glândulas Sebáceas/terapia , Resultado do TratamentoRESUMO
Between 1947 and 1992, 1403 patients with 1432 salivary gland tumours were treated at the Christie Hospital, Manchester. There were 1194 epithelial neoplasms: parotid, 1082 (91 per cent); submandibular, 47 (4 per cent); minor glands, 65 (5 per cent). The commonest histological diagnoses were pleomorphic adenoma (n = 776) and adenolymphoma (n = 159). A total of 244 carcinomas were seen (adenoid cystic carcinoma, n = 75). Treatment was primarily surgical, conservative where possible, and determined by tumour extent and not histology. Adjuvant radiation therapy was used in over half the definitively treated malignancies. The recurrence rate following the treatment of 551 new parotid pleomorphic adenomas was 1.6 per cent at median follow-up 12.5 (range 1-34) years, increasing to 15 per cent in the secondarily referred group (n = 170). For patients with definitively treated primary salivary carcinomas (n = 148), the disease-free survival rate at 5, 10 and 15 years was 58, 47 and 45 per cent respectively. Using multivariate analysis, clinical stage was the most important predictor of survival; the 10-year survival rate for stages I-IV was 96, 70, 47 and 19 per cent respectively.